U.S. market Closed. Opens in 17 hours 14 minutes

ORIC | ORIC Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of Revenue1.03M966.00K897.00K970.00K1.00MN/A
Gross Profit-1.03M-966.00K-897.00K-970.00K-1.00MN/A
Operating Expenses109.75M86.77M78.87M49.34M28.57M22.37M
Selling, General & Admin24.58M25.09M22.01M13.42M5.72M3.35M
Research & Development85.17M61.68M56.86M35.92M22.84M19.03M
Other Operating ExpensesN/A5.00M15.00K177.00K289.00K233.00K
Operating Income-110.78M-91.77M-78.87M-74.19M-28.57M-22.37M
Other Expenses / Income10.08M2.65M156.00K483.00K1.69M233.00K
Before Tax Income-100.70M-89.12M-78.72M-73.70M-26.88M-21.36M
Income Tax ExpensesN/A2.35M-1.04M23.57M-1.40M-1.01M
Net Income-100.70M-91.48M-77.68M-97.27M-25.49M-21.36M
Interest ExpensesN/A2.65MN/AN/AN/A-1.01M
Basic Shares Outstanding51.45M39.66M37.95M21.94M29.90M19.14M
Diluted Shares Outstanding51.45M39.66M37.95M21.94M29.90M19.14M
EBITDA-109.75M-81.77M-78.87M-24.50M-27.54M-21.47M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-100.70M-86.48M-78.72M-73.70M-26.88M-23.38M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙